Education
About Us
Working with TipRanks
Follow Us
Harrow Health Inc (HROW)
NASDAQ:HROW
Earnings Data
Report Date
Mar 25, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.39Last Year’s EPS
0.24Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth and successful product performances, particularly with VEVYE and IHEEZO, alongside significant strategic coverage wins for VEVYE. However, there were challenges with TRIESENCE's performance and potential issues with ImprimisRx that may affect future revenues.Company Guidance
Strong Revenue Growth
Total revenue for the third quarter was $71.6 million, representing a 45% increase over the same period in 2024 and a 12% sequential increase from the second quarter of this year.
VEVYE and IHEEZO Performance
VEVYE delivered 22% quarter-over-quarter revenue growth, and IHEEZO delivered 20% quarter-over-quarter revenue growth, both on track for a record year.
New Coverage Wins for VEVYE
Agreements signed with leading national payers for VEVYE, which will be listed on multiple new formularies with a preferred product status beginning January 2026.
Strategic Expansion
Preparing for 4 product launches over the next 3 years, including BYOOVIZ, OPUVIZ, BYQLOVI, and MELT-300.
Adjusted EBITDA and Operating Leverage
Adjusted EBITDA for the third quarter was $22.7 million. Operating expenses continue to be relatively stable quarter-to-quarter, showing operating leverage within new revenue gains.
HROW Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HROW Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 10, 2025 | $34.14 | $38.74 | +13.47% |
Aug 11, 2025 | $33.74 | $34.83 | +3.23% |
May 08, 2025 | $23.59 | $24.40 | +3.43% |
Mar 27, 2025 | $27.87 | $26.21 | -5.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Harrow Health Inc (HROW) report earnings?
Harrow Health Inc (HROW) is schdueled to report earning on Mar 25, 2026, After Close (Confirmed).
What is Harrow Health Inc (HROW) earnings time?
Harrow Health Inc (HROW) earnings time is at Mar 25, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is HROW EPS forecast?
HROW EPS forecast for the fiscal quarter 2025 (Q4) is 0.39.
